|
---|
Category:Letter
MONTHYEARML23229A0202023-08-17017 August 2023 Periodic Report Required by the License Conditions in Section 3.D.(1) of CPMIF-001 ML23087A2272023-05-0505 May 2023 Shine Technologies, LLC - Issuance of Amendment No. 4 to Construction Permit No. CPMIF-001 for the Receipt and Possession of Contained Special Nuclear Material ML23086C0502023-04-27027 April 2023 Shine Technologies, LLC - Letter, Environmental Assessment and Finding of No Significant Impact ML23088A3382023-04-0505 April 2023 Shine Technologies, LLC - Review of the Physical Security Plan in Support of an Operating License for a Medical Radioisotope Production Facility ML23010A1982023-02-24024 February 2023 Shine Technologies, LLC - Letter: Safety Evaluation Report for the Shine Medical Radioisotope Production Facility Operating License Application ML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML23034A1872023-02-0303 February 2023 Shine Medical Technologies, LLC Notice of Availability of Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility (Docket Number: 50-608) ML23010A2382023-02-0303 February 2023 Shine Technologies, LLC - Individual Notice of Consideration FRN Letter ML23023A0942023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0922023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23023A0862023-02-0202 February 2023 Notice of Availability of the Environmental Impact Statement Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML23024A1682023-02-0101 February 2023 Letter to Ken Westlake, EPA Region 5 - Issuance of Final EIS Supplement Related to the Operating License ML23024A1742023-02-0101 February 2023 Dr. Gregory Piefer, Chief Executive Officer - Issuance of Final EIS Supplement Related to the Operating License ML22287A1852023-02-0101 February 2023 Shine Technologies, LLC Regulatory Report on the Audit of Phased Startup Operations Application Supplement ML22308A2332023-01-0909 January 2023 Shine Technologies LLC - Regulatory Audit Report for Chapter 8 - Irradiation Facility and Radioisotope Production Facility Electrical Power Systems ML22347A2142023-01-0404 January 2023 Shine Technologies LLC - Regulatory Audit Report for I&C Combined Sessions ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22347A1772022-12-14014 December 2022 Shine Technologies LLC - Regulatory Audit Report for Programmable Logic Lifecycle ML22301A1492022-12-0707 December 2022 Shine Technologies, LLC - Regulatory Audit Report for Chapter 13 - Accident Analysis and Criticality Safety ML22322A2122022-12-0202 December 2022 Shine Medical Technologies - Cybersecurity Audit Summary Report ML22322A2232022-12-0202 December 2022 Shine Medical Technologies - Fire Protection Audit Summary Report ML22348A0672022-12-0101 December 2022 Shine Technologies, LLC - Request for Confirmatory Information Related to Instrumentation and Control Systems ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22292A3192022-11-30030 November 2022 Shine Medical Technologies, LLC Issuance of Order and Amendment No. 3 to Construction Permit No. CPMIF-001 ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22279A9512022-10-0606 October 2022 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 ML22271A9632022-09-28028 September 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 31 Revision to the Phased Startup Operations Application Supplement ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22220A2612022-09-12012 September 2022 Shine Technologies LLC - Regulatory Report on the Audit Chapter 14, Technical Specifications ML22251A3272022-09-0808 September 2022 Shine Technologies, LLC Application for an Operating License Revision 1 of Shine Response to Requests for Additional Information 7-38, 7-40, and 7-48 ML22249A1252022-08-31031 August 2022 Shine Technologies, LLC Final Safety Analysis Report - Application for an Operating License Supplement No. 30, Cover Letter ML22105A1102022-08-26026 August 2022 Shine Medical Technologies LLC - Request for Additional Information Related to the OGC Review of Phrase Approach ML22061A2122022-08-24024 August 2022 Shine Medical Technologies LLC - Regulatory Audit Plan for Phased Approach - Session 1 ML22213A0492022-08-0101 August 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22187A1342022-08-0101 August 2022 Shine Technologies, LLC - Update to Operating License Application Technical Review Schedule ML22206A2082022-07-27027 July 2022 Shine Medical Technologies, LLC - Request for Confirmatory Information Related to Radiation Protection Program and Waste Management ML22207A0062022-07-26026 July 2022 Shine Technologies, LLC Application for an Operating License Supplement No. 29 ML22202A4492022-07-21021 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 28 - Submittal of a Revision to the Shine Emergency Plan ML22188A2412022-07-14014 July 2022 Meeting with Shine Medical Technologies, LLC (EPID No. L-2019-NEW-0004), to Discuss Development of Shine'S Cybersecurity Program for It'S Medical Isotope Production Facility ML22175A0392022-07-11011 July 2022 Letter to Reid Nelson, Achp Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0542022-07-0808 July 2022 Letter to Gregory Piefer - Notice of Availability of the Draft EIS Supplement Related to the Operating License for the Shine Medical Isotope Production Facility ML22175A0912022-07-0808 July 2022 Notice of Availability and Request for Comments on the Draft Environmental Impact Statement Supplement Related to the Operating License for the Shine (Multiple Tribal Letters) ML22175A0772022-07-0808 July 2022 Letter to Daina Penkiunas - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22175A0632022-07-0808 July 2022 Letter to Ken Westlake, EPA Region 5 - Notice of Availability and Request for Comments on the Draft EIS Supplement Related to the Operating License for the Shine Facility ML22188A1942022-07-0707 July 2022 Shine Technologies, LLC, Application for an Operating License Supplement No. 27 ML22188A0562022-07-0707 July 2022 Shine Technologies, LLC Operating License Application Supplement No. 26 Submittal of a Revision to the Shine Material Control and Accounting Plan ML22223A0662022-07-0606 July 2022 Shine Technologies, LLC, Application for an Operating License, Revision 1 of the Response to Requests for Additional Information Related to Cyber Security ML22175A0742022-07-0101 July 2022 Letter to Mary Buelow Maintenance of Reference Materials at the Hedberg Public Library for the Environmental Review of Shine Medical Technologies, LLC Operating License Application 2023-08-17
[Table view] Category:Response to Request for Additional Information (RAI)
MONTHYEARML23048A2442023-02-17017 February 2023 Shine Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML22356A1932022-12-22022 December 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Confirmatory Information ML22335A5722022-12-0101 December 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22318A1782022-11-14014 November 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22304A1262022-10-31031 October 2022 Shine Technologies, LLC Application for an Operating License Response to Request for Confirmatory Information ML22263A3442022-09-20020 September 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22263A0272022-09-19019 September 2022 Shine Technologies, LLC - Application for an Operating License - Response to Request for Confirmatory Information ML22178A0352022-06-27027 June 2022 Enclosure 2 - Shine Technologies, LLC Application for an Operating License Revision 1 of the Shine Response to Requests for Additional Information 9-8 and 9-9 ML22143A8142022-05-23023 May 2022 Shine Technologies, LLC, Application for an Operating License Response to Request for Additional Information ML22112A1952022-04-22022 April 2022 Shine Technologies, LLC Application for an Operating License - Response to Request for Additional Information ML22094A0452022-04-0404 April 2022 Shine Technologies, LLC - Application for an Operating License Revision 1 of Shine Response to Part (C) of Request for Additional Information 7-9 ML22077A0862022-03-18018 March 2022 Shine Technologies, LLC Application for an Operating License - Supplement No. 20 and Response to Request for Additional Information ML22059A0202022-02-28028 February 2022 Enclosure 2: Shine Technologies, LLC - Response to Request to Additional Information ML22032A3422022-02-0101 February 2022 Shine Technologies, LLC, Application for an Operating License Revision 1 of the Shine Response to Request for Additional Information 11-2 ML22028A2242022-01-28028 January 2022 Shine Technologies, LLC, Response to Request for Additional Information on Application for an Operating License ML21364A0552021-12-30030 December 2021 Shine Technologies, LLC, Application for an Operating License Response to Request for Additional Information ML21350A1912021-12-16016 December 2021 Shine Technologies, LLC - Application for an Operating License Response to Request for Additional Information ML21326A2092021-11-22022 November 2021 Enclosure 3: Response to Request for Additional Information - Public Version ML21307A3062021-11-0303 November 2021 Shine Technologies, LLC, Application for an Operating License Response to Request for Additional Information ML21272A3442021-09-29029 September 2021 Shine Medical Technologies, LLC - Response to Request for Additional Information (Public Version) ML21271A0762021-09-28028 September 2021 Shine Medical Technologies, LLC, Application for an Operating License Revision 1 of Shine Response to Request for Additional Information 3.4-12 ML21243A2692021-08-31031 August 2021 Enclosure 2 - Response to Request for Additional Information Public Version ML21239A0492021-08-27027 August 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information ML21232A5872021-08-20020 August 2021 Shine Medical Technologies, LLC - Application for an Operating License Response to Request for Additional Information ML21232A6202021-08-20020 August 2021 Shine Medical Technologies, LLC Request to Amend Construction Permit No. CPMIF-001 - Response to Request for Additional Information ML21232A6232021-08-20020 August 2021 Enclosure 3: Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML21232A6212021-08-20020 August 2021 Enclosure 1: Request to Amend Construction Permit No. CPMIF-001 Response to Request for Additional Information ML21208A1352021-07-27027 July 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information ML21183A1282021-07-0202 July 2021 Enclosure 2: Shine Medical Technologies, LLC, Application for an Operating License, Response to Request for Additional Information Public Version ML21154A3032021-06-0303 June 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information 4a-15 ML21127A0512021-05-0707 May 2021 Shine Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information ML21095A2352021-03-23023 March 2021 Shine Medical Technologies, LLC, Cover Letter for Response to Request Tor Additional Information and Supplement No. 7 ML21095A2292021-03-23023 March 2021 Shine Medical Technologies, LLC, Response to Request for Additional Information and Supplement No. 7 ML21075A0122021-03-16016 March 2021 Shine Medical Technologies, LLC - Application for an Operating License, Revision 1 of Shine Response to Request for Additional Information 2.4-1 ML21029A1032021-01-29029 January 2021 Enclosure 1 - Response to Final Safety Analysis Report Chapters 2, 3, and 8 Requests for Additional Information ML21029A1052021-01-29029 January 2021 Enclosure 3 - Response to Final Safety Analysis Report Chapters 6 and 13 Requests for Additional Information ML21022A0272021-01-22022 January 2021 Shine Medical Technologies, LLC Application for an Operating License, Response to Environmental Requests for Additional Information ML21011A2402020-12-15015 December 2020 Shine Medical Technologies, LLC - Operating License Application Supplement No. 6 and Response to Request for Additional Information ML20357A0872020-12-10010 December 2020 Enclosure 3 - Response to Request for Additional Information ML20255A0282020-08-28028 August 2020 Enclosure 1 - Response to Request for Additional Information ML20188A3022020-06-17017 June 2020 Shine Medical Technologies, LLC - Response to Request for Additional Information on Operating License Application ML20129J9202020-05-0808 May 2020 Shine Medical Technologies, LLC, Application for an Operating License Response to Supplemental Environmental Requests for Additional Information ML20073E8802020-03-13013 March 2020 Shine Medical Technologies, LLC Application for an Operating License Response to Environmental Requests for Additional Information ML19071A0562019-03-0808 March 2019 Shine Medical Technologies, Inc., Affidavit & Response to Request for Additional Information to Application for Order Approving Indirect Transfer of Control of Construction Permit Response to Request for Additional Information ML17040A1382017-02-0707 February 2017 Shine Medical Technologies, Inc. Safeguards Information (SGI) Protection Program Response to Request for Additional Information ML15259A0242015-09-15015 September 2015 Shine Medical Technologies, Inc. - Application for Construction Permit, Revision 1 of Shine Response to Request for Additional Information 6b.3-34 ML15247A0672015-09-0202 September 2015 Shine Medical Technologies, Inc. Application for Construction Permit Response to Request for Additional Information ML15258A5982015-08-27027 August 2015 Enclosure 2 - Revision 1 of the Shine Response to RAI 12.1-1 and RAI 12.2-1 ML15222A2422015-07-23023 July 2015 Enclosure 2 - Attachment 3 - Atkins-NS-DAC-SHN-15-02, Revision 0 ML15222A2442015-07-23023 July 2015 Enclosure 2 - Attachment 2 - Atkins-NS-DAC-SHN-15-04, Revision 0 2023-02-17
[Table view] |
Text
June 3, 2021 2021-SMT-0062 10 CFR 50.30 U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555
References:
(1) SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License, dated July 17, 2019 (ML19211C143)
(2) NRC letter to SHINE Medical Technologies, LLC, SHINE Medical Technologies, LLC - Request for Additional Information Related Meteorological Data, Cooling Systems, and Physical Security Plan (EPID No. L-2019-NEW-0004), dated April 8, 2021 (ML21089A001)
(3) SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information, dated April 30, 2021 (ML21130A632)
(4) SHINE Medical Technologies, LLC, letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information, dated May 7, 2021 (ML21127A051)
SHINE Medical Technologies, LLC Application for an Operating License Response to Request for Additional Information 4a-15 Pursuant to 10 CFR Part 50.30, SHINE Medical Technologies, LLC (SHINE) submitted an application for an operating license for a medical isotope production facility to be located in Janesville, WI via Reference 1. Via Reference 2, the NRC staff determined that additional information was required to enable the staffs continued review of the SHINE operating license application. SHINE responded to a portion of the NRC staffs request via References 3 and 4. provides the SHINE response to Request for Additional Information (RAI) 4a-15.
If you have any questions, please contact Mr. Jeff Bartelme, Director of Licensing, at 608/210 1735.
I declare under the penalty of perjury that the foregoing is true and correct.
Executed on June 3, 2021.
101 E. Milwaukee Street, Suite 600 l Janesville, WI 53545 l P (608) 210-1060 l F (608) 210-2504 l www.shinemed.com
Document Control Desk Page 2 Very truly yours, James Costedio Vice President of Regulatory Affairs and Quality SHINE Medical Technologies, LLC Docket No. 50-608 Enclosure cc: Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health
ENCLOSURE 1 SHINE MEDICAL TECHNOLOGIES, LLC SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE RESPONSE TO REQUEST FOR ADDITIONAL INFORMATION 4A-15 The U.S. Nuclear Regulatory Commission (NRC) staff determined that additional information was required (Reference 1) to enable the continued review of the SHINE Medical Technologies, LLC (SHINE) operating license application (Reference 2). The following information is provided by SHINE in response to the NRC staffs request.
Chapter 4 - Irradiation Unit and Radioisotope Production Facility Description RAI 4a-15 Paragraph (b)(2) of Section 50.34, Contents of applications; technical information, to 10 CFR Part 50 requires, in part, that an FSAR include a description and analysis of the structures, systems, and components of the facility, with emphasis upon performance requirements, the bases, and the evaluations required to show that safety functions will be accomplished. The description shall be sufficient to permit understanding of the system designs and their relationship to safety evaluations.
The ISG to NUREG-1537, Part 2, Section 4a2.6, "Thermal-Hydraulic Design, states that the criteria for the thermal-hydraulic design should include that there be no coolant flow instability in any cooling coil that could lead to a decrease in cooling, and that the departure from nucleate boiling (DNB) ratio should be no less than 2.0 along a cooling coil. The NRC staff did not identify information in the FSAR to confirm that that any primary closed loop cooling system (PCLS) heat transfer surface, under any design conditions, will not undergo DNB.
Clarify whether any PCLS cooling surface, considering all system design conditions, could exceed critical heat flux resulting in DNB. If so, explain how such a condition is prevented and mitigated. If not, explain how much margin is available to avoid DNB in the worse-case scenario.
This information is necessary to confirm that primary coolant hydraulics and thermal conditions have been specified for the SHINE facility, consistent with the evaluation findings in the ISG to NUREG-1537, Part 2, Section 4a2.6. The analysis provided by the applicant should consider the various approaches and systems for heat removal, such as the cooling coils, the pool, and the gas management system. The analyses should give the limiting conditions of the features that ensure barrier integrity.
SHINE Response The primary closed loop cooling system (PCLS) cooled components include the target solution vessel (TSV) and the neutron multiplier.
Page 1 of 2
The PCLS cools the external surfaces of the TSV. The cooled material is uranyl sulfate target solution. The cooling water surrounding the TSV external surfaces cannot boil because the target solution is predominantly water. The target solution cannot increase in temperature beyond its boiling point due to phase change physics. The target solution is necessarily hotter than the cooling water because of the thermal resistance of natural convection between the target solution and TSV internal surfaces, conduction through the TSV walls, and forced convection between the TSV external surfaces and the cooling water. Additionally, the target solution cannot become significantly pressurized, as described in Subsection 4a2.7.6 of the FSAR. Therefore, the cooling water cannot reach its boiling point based on limitations of physics.
The PCLS cools the external surfaces of the neutron multiplier. The cooled material is natural uranium. The departure from nucleate boiling (DNB) ratio for the neutron multiplier in the worst-case power transient scenario is conservatively calculated to be 4.8 and DNB cannot occur.
SHINE has revised Subsection 4a2.7.3.1 of the FSAR to provide confirmation that PCLS heat transfer surfaces will not undergo DNB. A mark-up of the FSAR incorporating this change is provided as Attachment 1.
References
- 1. NRC letter to SHINE Medical Technologies, LLC, SHINE Medical Technologies, LLC -
Request for Additional Information Related Meteorological Data, Cooling Systems, and Physical Security Plan (EPID No. L-2019-NEW-0004), dated April 8, 2021 (ML21089A001)
- 2. SHINE Medical Technologies, LLC letter to the NRC, SHINE Medical Technologies, LLC Application for an Operating License, dated July 17, 2019 (ML19211C143)
Page 2 of 2
ENCLOSURE 1 ATTACHMENT 1 SHINE MEDICAL TECHNOLOGIES, LLC SHINE MEDICAL TECHNOLOGIES, LLC APPLICATION FOR AN OPERATING LICENSE RESPONSE TO REQUEST FOR ADDITIONAL INFORMATION 4A-15 FINAL SAFETY ANALYSIS REPORT CHANGES (MARK-UP) 1 page follows
Proprietary Information - Withheld from public disclosure under 10 CFR 2.390(a)(4)
Export Controlled Information - Withheld from public disclosure under 10 CFR 2.390(a)(3)
Chapter 4 - Irradiation Unit and Radioisotope Production Facility Description Thermal Hydraulic Design
[ ]PROP/ECI, the flow rate to CC3 is approximately [
]PROP/ECI.
The cooling water supply to the lower plenum of the SASS is at a pressure of up to approximately 20 pounds per square inch gage (psig) (138 kilopascal [kPa]) and a temperature of 59°F to 77°F (15°C to 25°C). The maximum PCLS cooling water temperature of 77°F (25°C) is used in the calculations presented in Subsection 4a2.7.5, below. This temperature limit is protected by the TSV reactivity protection system (TRPS) IU Cell Safety Actuation setpoints.
The TSV headspace pressure is maintained slightly below atmospheric pressure. The pressure over the target solution in the TSV is normally between -2 psig (-14 kPa) and 0 psig (0 kPa).
The cooling water pressure difference across the TSV within the SASS is less than approximately 7 psid (48 kPa), which accounts for entrance and exit pressure losses and frictional pressure losses in the cooling channels. See Table 5a2.2-1 for the PCLS parameters.
As the primary cooling water is maintained far from boiling even at atmospheric pressures, pressure profiles of the cooling water in the flow channels are not important for the heat transfer characteristics of the system. Total cooling water flow rate and inlet temperature are principal variables of importance for heat transfer. These variables are monitored by the TRPS.
As described above, the PCLS cools the external surfaces of the TSV. The cooled material is uranyl sulfate target solution. The PCLS cooling water surrounding the TSV external surfaces cannot boil because the target solution is predominantly water. The target solution cannot increase in temperature beyond its boiling point due to phase change physics. The target solution is necessarily hotter than the cooling water because of the thermal resistance of natural convection between the target solution and TSV internal surfaces, conduction through the TSV walls, and forced convection between the TSV external surfaces and the cooling water.
Additionally, the target solution cannot become significantly pressurized, as described in Subsection 4a2.7.6. Therefore, the cooling water cannot reach its boiling point based on limitations of physics.
As described above, the PCLS also cools the external surfaces of the neutron multiplier. The cooled material is natural uranium. The departure from nucleate boiling (DNB) ratio for the neutron multiplier in the worst-case power transient scenario is 4.8 and DNB cannot occur.
4a2.7.3.2 Chemical Effects Related to Heat Transfer The TSV is constructed of 347 stainless steel. The target solution is chemically compatible with this alloy of stainless steel. When 347 stainless steel is placed in a uranyl-sulfate solution at temperatures up to 212°F (100°C), the steel retains its metallic luster, and only after long periods of time does it develop a very thin tarnish film (Lane, 1958).
Plating out of chemicals on the TSV surfaces is not expected in the operating temperature range of the SHINE process. Plating out of chemicals onto surfaces can occur via two mechanisms: a layer of non-volatile material can be left on surfaces when water is removed by boiling or vaporizing, or a layer of material can form when soluble components are electro-chemically reduced to a non-soluble state. The TSV is maintained at a nominal 120°F (50°C) during irradiation, which is well below the boiling point of water, even at a pressure slightly below atmospheric. No plating out of chemicals is expected from boiling because no boiling will occur in the TSV. Evaporation of and collection of solid salts on the TSV walls at the liquid surface is SHINE Medical Technologies 4a2.7-5 Rev. 2